1. Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, Russell Square House, 10-12 Russell Square, London WC1B 5EH, UK
2. Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK
3. Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK/Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d’Hebron Institute of Research, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
4. UCL Institute of Cognitive Neuroscience, University College London, London, UK
5. Department of Neurology, Nuffield Department of Clinical Neurosciences, Oxford, UK
6. UK Dementia Research Institute, University College London, London, UK
7. UK Dementia Research Institute, University College London, London, UK/ Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden/Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden/Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK/Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China
8. Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK/National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, London, UK/Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK